Early aneurysm formation after everolimus-eluting stent implantation

Circ Cardiovasc Interv. 2014 Apr;7(2):266-7. doi: 10.1161/CIRCINTERVENTIONS.113.000945.

Authors

Mitul B Kadakia¹, Kelly C Epps, Maureen E Julien, Jeffrey Ogbara, Jay Giri, Daniel M Kolansky, Y Joseph Woo, Robert L Wilensky

Affiliation

¹ From the Cardiovascular Division, Department of Medicine (M.B.K., K.C.E., M.E.J., J.O., J.G., D.M.K., R.L.W.) and Division of Cardiovascular Surgery (Y.J.W.), Hospital of the University of Pennsylvania, Philadelphia.

PMID: 24737336
DOI: 10.1161/CIRCINTERVENTIONS.113.000945

No abstract available

Keywords: acute coronary syndrome; coronary aneurysm; drug-eluting stent; stent.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Coronary Aneurysm / diagnosis*
Coronary Aneurysm / etiology*
Coronary Aneurysm / surgery
Coronary Angiography
Coronary Artery Bypass
Drug-Eluting Stents / adverse effects*
Electrocardiography
Everolimus
Female
Humans
Myocardial Infarction / therapy*
Sirolimus / adverse effects
Sirolimus / analogs & derivatives*
Treatment Outcome
Vasculitis, Leukocytoclastic, Cutaneous / chemically induced
Vasculitis, Leukocytoclastic, Cutaneous / complications
Vasculitis, Leukocytoclastic, Cutaneous / diagnosis

Substances

Everolimus
Sirolimus